Hunter Shkolnik, Partner, NSPR Law Services, Appointed Executive Committee for the Self-Funded Payer Track Insulin Pricing Litigation Case No. 2:23-md-03080 (BRM)(RLS) MDL No. 3080

New Jersey Class Action Lawsuit Accuses three of the biggest makers of diabetes drugs, Novo Nordisk, Sanofi SA and Eli Lilly & Co, of scheming to inflate the drugs' prices

Hunter Shkolnik, a Partner in NSPR Law Services — widely considered one of the country’s leading personal injury attorneys — has been appointed to the Executive Committee for the Self -Funded Payer Track Insulin Pricing Litigation Case No. 2:23-md-03080 (BRM)(RLS) MDL No. 3080, currently in the N.J. courts under the jurisdiction of Judge Brian R. Martinotti and Judge Rukhsana l. Singh.

In that role, he will collaborate with a selection of peers on the management of the litigation and leadership structures for Plaintiffs spanning self-funded payers or self-funded payer groups, including local governments and subdivisions (including county, borough, municipality, city, town, township, parish, local public authority, special district, intrastate district, council of governments, and agencies or instrumentalities of multi-regional or intra-state or local government); unions; schools and educational institutions; for-profit and non-profit organizations; and other similar self-funded payers who pay for prescription drugs provided to members of their health plan with prescription drug coverage.

About the Insulin Pricing Scheme

One in four healthcare dollars is spent caring for people with diabetes. The price range for insulin can range from $300 to $700 despite costing manufacturers as little as $2 to produce.

The Insulin Pricing Scheme class action lawsuit brought by consumers in multiple states claims the defendants - all major players in the pharma industry – engineered insulin price increases via an opaque, conspiratorial kickback scheme which has exponentially increased their profits at the expense of payors like Plaintiff and its plan members. The Insulin Pricing Scheme is a multibillion-dollar industry with many of the corporate defendants listed in the top 20 of the 2022 Fortune 500 list.

About Hunter Shkolnik

For over thirty-five years, Hunter Shkolnik has advocated for the rights of clients harmed by medical malpractice, the opioid epidemic, defective products, accidents, and more.

He is a Founding partner of Napoli Shkolnik, a top mass tort litigation firm that has played an integral role in achieving multi-million-dollar verdicts and settlements across all practice areas.

Highlights of his litigation career include representing Nassau County, N.Y. in the first jury opioid trial which yielded up to $1.7 billion from the defendants including Johnson & Johnson; Allergan; Endo and Par; and others; serving as a Plaintiff Executive Committee Member in the National Prescription Opiate Litigation MDL, which secured a $3.1 Billion settlement against national pharmacy chains; being the lead attorney on one of the first lawsuits on behalf of a former Marine exposed to toxic water at Camp Lejeune; serving as Co-Liaison Counsel in the Flint Water Crisis litigation, which resulted in a landmark settlement of more than $626 million on behalf of the residents of Flint and other cases.

As a sought-after legal and political news analyst and media commentator, his professional opinion on civil and criminal law is regularly featured in publications such as Reuters, The New York Times, Newsday, Yahoo, Law360, The New York Law Journal, Law.com, Bloomberg, and others. Notable TV appearances include CNN, NBC, 7-News Miami, Newsmax, Fox News, Fox Business, WABC-7 Eyewitness News, Law and Crime Network, and more. His insight on environmental racism, the Flint Water Crisis, and Steven Avery (of Making a Murderer fame) can also be heard on podcasts like Crime Stories with Nancy Grace, Mass Tort News LegalCast, and Good Law Bad Law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231218503084/en/